Li Yiping James - Net Worth and Insider Trading
Li Yiping James Net Worth
The estimated net worth of Li Yiping James is at least $36 Million dollars as of 2024-09-13. Li Yiping James is the 2201 Interest of corporation controlled by you of JW (Cayman) Therapeutics Co Ltd and owns about 27,829,975 shares of JW (Cayman) Therapeutics Co Ltd (HKSE:02126) stock worth over $36 Million. Details can be seen in Li Yiping James's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Li Yiping James has not made any transactions after 2023-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Li Yiping James
Li Yiping James Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Li Yiping James owns 1 companies in total, including JW (Cayman) Therapeutics Co Ltd (HKSE:02126) .
Click here to see the complete history of Li Yiping James’s form 4 insider trades.
Insider Ownership Summary of Li Yiping James
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02126 | JW (Cayman) Therapeutics Co Ltd | 2023-06-07 | 2201 Interest of corporation controlled by you |
Li Yiping James Latest Holdings Summary
Li Yiping James currently owns a total of 1 stock. Li Yiping James owns 27,829,975 shares of JW (Cayman) Therapeutics Co Ltd (HKSE:02126) as of June 7, 2023, with a value of $36 Million.
Latest Holdings of Li Yiping James
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02126 | JW (Cayman) Therapeutics Co Ltd | 2023-06-07 | 27,829,975 | 1.30 | 36,178,968 |
Holding Weightings of Li Yiping James
Li Yiping James Form 4 Trading Tracker
According to the SEC Form 4 filings, Li Yiping James has made a total of 4 transactions in JW (Cayman) Therapeutics Co Ltd (HKSE:02126) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in JW (Cayman) Therapeutics Co Ltd is the sale of 0 shares on June 7, 2023, which brought Li Yiping James around $0.
Insider Trading History of Li Yiping James
- 1
Li Yiping James Trading Performance
Li Yiping James Ownership Network
Li Yiping James Owned Company Details
What does JW (Cayman) Therapeutics Co Ltd do?
Who are the key executives at JW (Cayman) Therapeutics Co Ltd?
Li Yiping James is the 2201 Interest of corporation controlled by you of JW (Cayman) Therapeutics Co Ltd. Other key executives at JW (Cayman) Therapeutics Co Ltd include 2202 Interest of your spouse Li Dan , 2501 Other Syracuse Biopharma (Cayman) II, Ltd. , and 2201 Interest of corporation controlled by you Bristol-myers Squibb Company .
JW (Cayman) Therapeutics Co Ltd (HKSE:02126) Insider Trades Summary
Over the past 18 months, Li Yiping James made 1 insider transaction in JW (Cayman) Therapeutics Co Ltd (HKSE:02126) with a net sale of 0. Other recent insider transactions involving JW (Cayman) Therapeutics Co Ltd (HKSE:02126) include a net sale of 0 shares made by Li Dan ,
In summary, during the past 3 months, insiders sold 0 shares of JW (Cayman) Therapeutics Co Ltd (HKSE:02126) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of JW (Cayman) Therapeutics Co Ltd (HKSE:02126) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
JW (Cayman) Therapeutics Co Ltd (HKSE:02126)'s detailed insider trading history can be found in Insider Trading Tracker table.
JW (Cayman) Therapeutics Co Ltd Insider Transactions
Li Yiping James Mailing Address
Above is the net worth, insider trading, and ownership report for Li Yiping James. Currently GuruFocus does not have mailing address information for Li Yiping James.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
